No information is available on the use of baricitinib during breastfeeding. Expert opinion recommends that mothers not breastfeed while taking baricitinib.[1] An alternate drug is preferred, especially while nursing a newborn or preterm infant. The manufacturer recommends that women avoid nursing during therapy and for 4 days after the last dose.
关于哺乳期使用巴瑞替尼的信息尚无可用资料。专家意见建议母亲在服用巴瑞替尼期间不要进行母乳喂养。[1] 首选替代药物，尤其是在哺育新生儿或早产儿期间。制造商建议女性在治疗期间及最后一剂后4天内避免哺乳。
